ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Kidney Transplantation Does Not Reverse the Premature T Cell Ageing in End-Stage Renal Disease Patients

R. Meijers, N. Litjens, E. de Wit, A. Langerak, C. Baan, W. Weimar, M. Betjes

Internal Medicine Section Nephrology and Transplantation, Erasmus MC, Rotterdam, Netherlands
Immunology, Erasmus MC, Rotterdam, Netherlands

Meeting: 2013 American Transplant Congress

Abstract number: A648

Background End-stage renal disease (ESRD) patients have a defective T cell mediated immune system which is related to excessive premature ageing of the T cell compartment. This is believed to be caused by the uremia-induced pro-inflammatory conditions. Kidney transplantation (KTx) reduces this pro-inflammatory environment and the aim of this study is to investigate whether KTx is able to reverse premature immunological ageing.

Methods For this purpose, we followed 140 KTx recipients excluding cytomegalovirus (CMV)pos donor/CMVneg recipient combinations as primary CMV infection influences T cell differentiation status. KTx recipients were followed prior to and at 3, 6 and 12 months post KTx and their circulating T cells studied using several T cell ageing parameters. First, thymic output was assessed by determining the T cell receptor excision circle (TREC) content together with % CD31+ naÏve T cells. Relative telomere length (RTL) was determined as a measure for proliferative history and immunophenotyping was used to establish the differentiation status of circulating T cells.

Results The TREC content, % of CD31+ naÏve T cells as well as the RTL of CD4+ and CD8+ T cells remained unaltered within the first year post KTx. The absolute number of CD4+ as well CD8+ T cells decreased 3 months after KTx mainly due to a decrease in memory T cells and in particular the more differentiated T cells (p<0.001 for both CD4+ EM and CD8+ EMRA population). At 12 months post transplantation the number of CD8+ EMRA T cells reached again pre-KTx values. Remarkably, the number CD4+ EM T cell population remained significantly low (p<0.05) within the first year post KTx (i.e. 189.4±15.3 cells/ml pre vs 136.3±13.7 cells/ml at 12 months).

Conclusion The prematurely aged T cell compartment of ESRD patients is not reversed by kidney transplantation. Loss of thymic function and excess of highly differentiated aged T cells seem permanent and therefore remain important determinants of a dysfunctional immune system after transplantation

(This study was financially supported by the Dutch Kidney Foundation (KSPB.10.12)).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Meijers R, Litjens N, Wit Ede, Langerak A, Baan C, Weimar W, Betjes M. Kidney Transplantation Does Not Reverse the Premature T Cell Ageing in End-Stage Renal Disease Patients [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/kidney-transplantation-does-not-reverse-the-premature-t-cell-ageing-in-end-stage-renal-disease-patients/. Accessed May 15, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences